On May 17, 2023, the Board of Directors of PetMed Express, Inc. approved the appointment of Sandra Y. Campos as a director on its Board, and also approved the appointment of Ms. Campos as a member on the Corporate Governance and Nominating Committee, the Audit Committee and the Compensation Committee, effective May 17, 2023. In connection with Ms. Campos’s appointment on the Board, the Board voted to increase the size of the Board by one director to seven persons effective May 17, 2023. Ms. Campos, 56, served as the Chief Executive Officer of DVF (Diane von Furstenberg) from April 2018 to November 2020. Prior to joining DVF, Ms. Campos was the Co-President, Women’s Apparel, of Global Brands Group Holding Limited from 2015 to April 2018, which included the Juicy Couture, Bebe, Buffalo, Tretorn, BCBG and Herve Leger brands. Ms. Campos also has held leadership roles prior thereto with apparel companies Polo Ralph Lauren and Nautica International. Ms. Campos also founded Fashion Launchpad in June 2020, and created Dream out Loud in partnership with Selena Gomez which was established in 2009, and launched at retail in 2010. After her departure from DVF, Ms. Campos served as the Chief Executive Officer of Project Verte Inc. from November 2020 until November 2021. A receivership proceeding was filed against Project Verte Inc. in August 2022 in the Delaware Court of Chancery. The receiver subsequently filed a bankruptcy proceeding under Chapter 7 of the U.S. Bankruptcy Code with respect to Project Verte Inc. in January 2023 in the U.S. Bankruptcy Court for the District of Delaware. Ms. Campos has been a member of the board of directors of Big Lots, and a member of its audit committee and capital allocation planning committee since May 2021; an operating advisor of ShoulderUp Technology Acquisition Corp. (SPAC) since October 2021; a member of the board of directors of Fabric since August 2022, and; a member of the board of directors of PureRED, since March 2023.
On May 16, 2023, Jodi Watson informed the Board that she does not wish to stand for re-election to the Board when her term expires at the Company’s 2023 Annual Meeting of Shareholders on August 3, 2023. Accordingly, Ms. Watson, who has served as a member of its Board since May 2021, will not be nominated by the Board for election at its 2023 Annual Meeting, and Ms. Watson's term as a director will end when her current term expires at its 2023 Annual Meeting.
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.
PETMED EXPRESS, INC. 
